The chemical class known as ARL5C inhibitors encompasses a diverse group of compounds that share the common feature of interfering with the activity or function of the ADP-ribosylation factor-like 5C (ARL5C) protein. ARL5C is a member of the ADP-ribosylation factor (ARF) family, which plays a pivotal role in various cellular processes, including intracellular vesicle trafficking, membrane dynamics, and organelle organization. ARL5C inhibitors are designed to modulate these processes by targeting the specific interactions, conformations, or enzymatic activities of the ARL5C protein. Structurally, ARL5C inhibitors can vary widely, ranging from small molecules to peptides and peptidomimetics. These compounds are typically designed or selected through various methods, such as high-throughput screening, structure-based drug design, virtual screening, and molecular docking. Some inhibitors may directly interact with the ARL5C protein, either at its active site or at specific binding interfaces critical for its function. Others may work indirectly by affecting the activity of proteins or pathways that interact with or are regulated by ARL5C.
ARL5C inhibitors exhibit a range of mechanisms of action. They might inhibit nucleotide binding or hydrolysis, disrupt protein-protein interactions involving ARL5C, or interfere with its subcellular localization. By modulating ARL5C's function, these inhibitors can perturb vesicle trafficking pathways, alter membrane dynamics, and potentially impact the organization of organelles like the Golgi apparatus. Given the vital role of ARL5C in cellular processes, the development and study of ARL5C inhibitors hold promise for advancing our understanding of intracellular dynamics. These inhibitors serve as valuable tools in deciphering the intricate mechanisms underlying vesicle trafficking and membrane dynamics, enabling researchers to uncover new insights into fundamental cellular processes. Through these efforts, a deeper understanding of cellular processes and potential avenues for future research may be unveiled.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
Although not a direct inhibitor of ARL5C, BFA is a well-known compound that disrupts various cellular processes, including vesicle trafficking, by interfering with certain ADP-ribosylation factor (ARF) proteins. It indirectly affects ARL5C-regulated pathways. | ||||||
Golgicide A | 1005036-73-6 | sc-215103 sc-215103A | 5 mg 25 mg | $191.00 $683.00 | 11 | |
This is a compound that disrupts Golgi morphology and function by inhibiting the activity of several small GTPases, including some members of the ARF family. It indirectly affects ARL5C-regulated processes. | ||||||